Akers biosciences股票预测
14 May 2020 Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules. 14 May 2020 Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP Akers Bio develops, manufactures, and supplies rapid, point-of-care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. All of Akers Bio’s rapid, single-use tests are performed in vitro (outside the body) and are Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests. Akers Biosciences Inc. all SEC filings breakout by MarketWatch. View the AKER U.S. Securities and Exchange Commission reporting information. Stock analysis for Akers Biosciences Inc (AKER:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. * AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios.
Akers Biosciences (AKER) reports earnings on 8/14/2020. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.
亿帆医药（个股资料 操作策略 盘中直播 独家诊股）. 亿帆医药事件点评:并购NovoTek,国际化进展再露峥嵘. 亿帆医药 002019. 研究机构：东兴证券 分析 BD Biosciences provides flow cytometers, reagents, tools, and a wide range of services to support the work of researchers and clinicians who understand disease and improve care. Shares of Akers Biosciences Inc. (NASDAQ:AKER) surged 15.8% to close at $3.22 following the completion of a clinical trial on the company's Chlamydia rapid 由专业分析师提供的Akers Biosciences(AKER)股票分析报告，千股千评。包括行情 走势分析，股价预测，精准股评，投资策略分析及股票买卖操作建议。
Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests.
提供Akers Biosciences Inc(AKER)股票的行情走势、五档盘口、逐笔交易等实时行情数据，及Akers Biosciences Inc(AKER)的资讯、公司公告、研究报告、行业研报、F10资料、行业资讯、资金流分析、阶段涨幅、所属板块、财务指标、机构观点、行业排名、估值水平、股吧互动等与Akers Biosciences Inc(AKER)有关的信息和 新浪财经-美股频道为您提供aker(aker)股票股价,股票实时行情,新闻,财报,美股实时交易数据,研究报告,评级,财务指标分析等与aker(aker)股票相关的信息与服务 郑重声明：本网站所刊载的所有资料及图表仅供参考使用。投资者依据本网站提供的信息、资料及图表进行金融、证券等投资
Find the latest Akers Biosciences Inc. (AKER) stock quote, history, news and other vital information to help you with your stock trading and investing.
* AKERS BIOSCIENCES INC FILES FOR OFFER OF UP TO 793,437 SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING Source text: (https://bit.ly/2ZstE7n) Further company coverage: BRIEF-Akers Akers Biosciences Inc. annual stock financials by MarketWatch. View the latest AKER financial statements, income statements and financial ratios. Akers Biosciences (AKER) reports earnings on 8/14/2020. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. Contact our support team if you have any enquiries about any of our products. Call: (856) 848-8698. Email: info@akersbio.com Akers Biosciences, Inc. (the “Company”) (AKER), a developer of rapid health information technologies, today announced that Premas Biotech, its partner in the development of a vaccine candidate
Akers Biosciences Inc. Akers Biosciences, Inc. engages in the development, manufacture, and supply of screening and testing products. Its products include clinical diagnostics and safety tests.
查看最新的Akers Biosciences Inc. (AKER) 股票報價、記錄、新聞及其他重要資訊， 助你賣買股票及投資。 遠期股息及收益率, 無(無). 除息日, 無. 1 年預測目標價, 無